Clinical Trials for PROGEN

Fecal MicrobiotaTransplant for the Treatment of Parkinson's Disease

Phase 2 Randomized Study of PG-102 vs Placebo and Semaglutide in Type 2 Diabetes Mellitus

Familial Fecal Microbiota Transplant for the Treatment of Subjects With Autism Spectrum Disorders

Screening for Alpha-1 Antitrypsin Deficiency in Patients With Airway Obstruction

A Phase I Study of SPGL008 in Subjects With Advanced Malignant Tumors

Phase I Clinical Study to Evaluate the Safety and Efficacy of RGB-5088 in Patients With Type 1 Diabetes Mellitus

177Lu-PSMA (177Lu-PNT2002) in PSMA-Positive Adenoid Cystic Carcinoma

Phase II Study of PG-102(MG12) Compared With Placebo in Obesity and Type 2 Diabetes

Regenn® Therapy System Safety Study

Breast Cancer PSMA PET

Evaluation of the Change in PSMA Expression in Prostate Cancer in Response to Hormonal Therapy

Endometrial Cell Collection With the PadKit

Pilot of 18F-DCFPyL-PSMA PET in mCRPC Patients Receiving 117Lu-Vipivotide Tetraxetan

DETEC® Esterase for Screening Wound Infection at Point of Care

Efficacy of ProgenaMatrix™ in the Management of DFUs

Randomized Trial of Five or Two MRI-Guided Adaptive Radiotherapy Treatments for Prostate Cancer

DETEC® pH Point of Care Wound Diagnostic Test

A Study to Explore the Role of Gut Flora in COVID-19 Infection

PSMA-PET Imaging for Detecting Early Metastatic Prostate Cancer in Men w/ High Decipher Test Scores

Prostate-Specific Membrane Antigen (PSMA) PET Scans in People Prostate Cancer

PET/MRI for the Staging of Newly Diagnosed Prostate Cancer

PSMA-PET Guided Radiotherapy

Study of PSMA-targeted 18F-DCFPyL PET/CT for the Detection of Clinically Significant Prostate Cancer

Small Intestinal Bacterial Overgrowth: A Prospective Registry